Balyasny Asset Management’s Gossamer Bio GOSS Stock Holding History

Balyasny Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.2K	Sell	1,303 -72,726	-98%	-$1.62M	﹤0.01%	2927
2026 Q1	$1.95M	Buy	74,029 +55,070	+290%	+$6.92M	﹤0.01%	1793
2025 Q4	$4.7M	Buy	18,959 +9,327	+97%	+$2.13M	0.01%	1426
2025 Q3	$2.03M	Buy	+9,632	New	+$1.7M	﹤0.01%	1783
2025 Q2	–	Sell	-3,616	Closed	-$318K	–	3021
2025 Q1	$318K	Buy	+3,616	New	+$334K	﹤0.01%	2431
2024 Q2	–	Sell	-1,225	Closed	-$116K	–	2770
2024 Q1	$116K	Buy	+1,225	New	+$108K	﹤0.01%	2486
2023 Q3	–	Sell	-184	Closed	-$17.6K	–	2437
2023 Q2	$17.6K	Buy	+184	New	+$18.3K	﹤0.01%	2160
2022 Q4	–	Sell	-584	Closed	-$560K	–	2948
2022 Q3	$560K	Buy	+584	New	+$580K	﹤0.01%	2001

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Balyasny Asset Management's GOSS Position: Q2 2026 in Review

Balyasny Asset Management reduced its Gossamer Bio (GOSS) stake by 98% in Q2 2026, selling an estimated $1.62M and leaving 1,303 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

Balyasny Asset Management first reported a position in GOSS in Q3 2022 and has held it in 8 quarters since. The position peaked at $4.7M in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Balyasny Asset Management held 1,303 shares of Gossamer Bio worth $17.2K as of Q2 2026.
Balyasny Asset Management sold 72,726 Gossamer Bio shares in Q2 2026, an estimated $1.62M.
Gossamer Bio made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2927 holding.
Balyasny Asset Management first reported a position in Gossamer Bio in Q3 2022 and has held it in 8 quarters since.
Balyasny Asset Management's Gossamer Bio position peaked at $4.7M in Q4 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.